1. Home
  2. RXRX vs AAPG Comparison

RXRX vs AAPG Comparison

Compare RXRX & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$3.80

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$19.08

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXRX
AAPG
Founded
2013
2009
Country
United States
China
Employees
N/A
767
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
RXRX
AAPG
Price
$3.80
$19.08
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$7.50
$48.40
AVG Volume (30 Days)
14.2M
7.3K
Earning Date
05-06-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
14.79
N/A
EPS
N/A
N/A
Revenue
$74,681,000.00
N/A
Revenue This Year
$12.11
$290.34
Revenue Next Year
$82.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
26.92
N/A
52 Week Low
$2.77
$18.56
52 Week High
$7.18
$48.45

Technical Indicators

Market Signals
Indicator
RXRX
AAPG
Relative Strength Index (RSI) 65.33 38.26
Support Level $2.85 $18.56
Resistance Level $3.99 $27.98
Average True Range (ATR) 0.23 0.90
MACD 0.08 0.07
Stochastic Oscillator 90.28 18.16

Price Performance

Historical Comparison
RXRX
AAPG

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: